Karyopharm Therapeutics: 2Q Earnings Snapshot

August 7, 2018

NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported a loss of $33.7 million in its second quarter.

The Newton, Massachusetts-based company said it had a loss of 60 cents per share.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The pharmaceutical company posted revenue of $19.9 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $6 million.

Karyopharm Therapeutics shares have increased 84 percent since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI

Update hourly